CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 512 shares at an average $541.02 ($277,000)
- 4 Grant or award Director acquired 11 shares (grant or award)
- 4 Grant or award Director acquired 36 shares (grant or award)
- 4 Grant or award Director acquired 36 shares (grant or award)
- 4 Exercise or conversion Senior Vice President acquired 3,227 shares (option exercise)
- 4 Exercise or conversion Executive Vice President acquired 1,476 shares (option exercise)
- 4 Open-market sale Director sold 3,046 shares at $513.41 ($1,563,840)
- 4 Exercise or conversion Director acquired 1,476 shares (option exercise)
- 4 Exercise or conversion SVP, Gen. Counsel & Secretary acquired 483 shares (option exercise)
- 4 Exercise or conversion President & CEO acquired 1,475 shares (option exercise)
- 4 Open-market sale Director sold 1,898 shares at an average $538.57 ($1,022,207)
- 4 Open-market sale Director sold 1,000 shares at $555.56 ($555,561)
- 4 Exercise or conversion Executive VP & CFO acquired 1,474 shares (option exercise)
- 4 Open-market sale President & CEO sold 13,868 shares at an average $537.21 ($7,449,969)
- 4 Open-market sale Director sold 7,331 shares at an average $536.91 ($3,936,089)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 74 · 1,467 filings